BMRA: Biomerica Projected Price to Earnings

BMRA (Biomerica, Inc.) - company brandmark

Biomerica, Inc. (BMRA) relies on the expertise of biochemists and laboratory technicians who value a culture of scientific precision. A stable engineering staff and moderate hiring of IT developers ensure the preservation of core competencies. Physician trust spanning half a century confirms the reliability of food intolerance tests. The company's forward P/E demonstrates the asset's valuation dynamics, where 0.00 serves as the parameter's baseline value.

Market Cap to Projected Earnings: biomerica.com (BMRA) for 07/04/2022 - 11/17/2026

Analytical breakdowns and data insights for company Biomerica, Inc. (BMRA)

- stock value and consensus price forecast:
General company analysis:Biomerica Inc
Signature product of Biomerica Inc

Biomerica, Inc. optimizes costs by utilizing outsourcing for the production of test systems, which directly impacts projected net income. By evaluating the ratio of the current share price to expected earnings, an investor determines the premium paid for future growth by analyzing changes in the company's forward P/E ratio. A decline in this indicator signals that the asset is undervalued, confirming the resilience of its capitalization to external market shocks.

Main competitors

Forward P/E Multiple A|DGX - Projected Price to Earnings Ratio|Illumina Inc - Projected Price to Earnings|exactsciences.com (EXAS) - Projected Price to Earnings Ratio|RVTY - Future Price to Earnings|Market Cap to Projected Earnings Bio-Rad Laboratories, Inc. BIO|NNNN: Forward P/E Multiple|SHC - Market Cap to Projected Earnings|Future Price to Earnings quidel.com|Projected Price to Earnings Ratio opko.com OPK|Forward P/E Multiple CDNA|Projected Price to Earnings Maravai LifeSciences Holdings, Inc. MRVI|Fulgent Genetics Inc - Projected Price to Earnings|Forward P/E Multiple Standard BioTools Corp LAB|CTKB: Projected Price to Earnings|OSUR - Forward P/E Multiple|XGN: Forward P/E Multiple|MDxHealth - Future Price to Earnings Multiple|LUCD (Lucid Diagnostics Inc.) - Forward P/E Multiple|PRE (Prenetics Global) - Market Cap to Future Earnings Ratio|Forward P/E Multiple IMDX|Market Cap to Future Earnings Ratio TRIB|Future Price to Earnings ProPhase Labs Inc PRPH|Market Cap to Projected Earnings Ainos Inc (AIMD)|CODX - Future Price to Earnings|Projected Price to Earnings Ratio Heart Test Labs|CDIO: Forward P/E Multiple|Price to Future Earnings Ratio ONCO|Future Price to Earnings Virax Biolabs|Bluejay Diagnostics, Inc. (BJDX) - Market Cap to Projected Earnings|Future Price to Earnings Aspira Women's Health (AWH)|AXDX (Accelerate Diagnostics, Inc) - Future Price to Earnings Multiple|CENTOGENE, N.V. - Projected Price to Earnings|Future Price to Earnings Multiple ENZ|Future Price to Earnings Multiple fresh2.co (FRES)|GENE (Genetic Technologies Limited) - Price to Future Earnings Ratio|ME: Forward P/E Multiple|Price to Future Earnings Ratio PMD